Adam J. Gordon

Differences in medicaid expansion effects on buprenorphine treatment utilization by county rurality and income: A pharmacy data claims analysis from 2009–2018

B. Andraka-Christou, Mark Sorbero, Flora Sheng, 2023, Drug and alcohol dependence reports.

Commentary With Study Protocol: Implementation and Effectiveness of Mindfulness-Oriented Recovery Enhancement (MORE) as an Adjunct to Methadone Treatment for Opioid Use Disorder (IMPOWR-MORE).

Nina A. Cooperman, Adam J. Gordon, Eric L. Garland, 2024, Substance use & addiction journal.

Using the Delphi Process to Prioritize an Agenda for Care Transition Research for Patients With Substance Use Disorders

Adam J. Gordon, M. Incze, Sophia Huebler, 2024, Substance use & addiction journal.

"They Ask Questions, But They Don't Want the Answers"-Perceptions of Clinical Communication Among Veterans Discontinuing Buprenorphine for the Treatment of Opioid Use Disorder.

B. Morasco, Jessica J. Wyse, S. Shull, 2024, Substance use & addiction journal.

A Systematic Review of State Office-Based Buprenorphine Treatment Laws Effective During 2022: Counseling, Dosage, and Visit Frequency Requirements

B. Andraka-Christou, Olivia K. Golan, Adam J. Gordon, 2024, Substance use & addiction journal.